pharma · Migraine · Narcolepsy
H. Lundbeck A/S
H. Lundbeck A/S is a pharma organization headquartered in Valby, CN. Primary therapeutic focus areas include Migraine, Narcolepsy, Schizophrenia, Multiple System Atrophy, Chronic Migrane, Migrane, Medication Overuse Head
Postboks 361, LYSAKER, Bærum 1326, NO, Valby, CN HQ
112 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Postboks 361, LYSAKER, Bærum 1326, NO, Valby, CN
- Employees
- 112
- Programs
- 17
- Drugs
- 14
- Patents
- 0
20453A
Phase 1 · other · Active, moderate-to-severe TED
20453A for Active, moderate-to-severe TED is a Phase 1 program (other) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).
Internal code 20453A
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- H. Lundbeck A/S
- Phase
- Phase 1
- Modality
- other
- Indication
- Active, moderate-to-severe TED
- Status
- active
- Trials
- 1